Discontinuation and reinitiation of pharmacological treatment for ADHD among individuals with ADHD and substance use disorder CONCLUSIONS: The results suggest less treatment continuity and access for those with ADHD and comorbid SUD. via https://pubmed.ncbi.nlm.nih.gov/41871884/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1HYeX0emtvYgH07Wkz0a8n9otrdMd-JIklc_uo0I5vh1u9WMEy&fc=None&ff=20260324020806&v=2.19.0.post6+133c1fe
